SANTHERA PHARMACEUTICALS HOLDING AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.5 CHF | 0.00% |
|
+1.39% | -3.16% |
| Apr. 25 | Transcript : Santhera Pharmaceuticals Holding AG, 2023 Earnings Call, Apr 25, 2024 | |
| Apr. 25 | Santhera Pharmaceuticals Swings to Profit in FY23; Revenue Grows | MT |
Chart calendar Santhera Pharmaceuticals Holding AG
c1c67a0523ab766148.0bvI-qKpYtqeaPykvsfuCez7oNUa6z3iuFBmzKg4XoU.i8O4ve32JezIO52J6pDYfaSskZAqiWiO2zYygsNcE92g0ZGsy_AJ78wLrQ~e7392adb3e0ffef052c350cd4408f556
Upcoming events on Santhera Pharmaceuticals Holding AG
Past events on Santhera Pharmaceuticals Holding AG
| 2024-04-25 08:30 am | Q4 2023 Earnings Call |
| 2024-04-25 01:00 am | Q4 2023 Earnings Release |
| 2023-10-02 | World Muscle Society Congress |
| 2023-09-12 10:00 am | H.C. Wainwright Global Investment Conference |
| 2023-09-07 08:30 am | Q2 2023 Earnings Call |
| 2023-09-07 01:00 am | Q2 2023 Earnings Release |
| 2023-07-02 | Reverse Split: 1 of 10 |
| 2023-06-28 | PPMD Conference |
| 2023-06-27 04:00 am | Annual General Meeting |
| 2023-04-27 08:30 am | Q4 2022 Earnings Call |
| 2023-04-27 01:00 am | Q4 2022 Earnings Release |
| 2023-03-18 | MDA Clinical & Scientific Conference |
| 2022-11-29 04:30 am | Extraordinary Shareholders Meeting |
| 2022-11-07 08:30 am | Interim 2022 Earnings Call |
| 2022-10-31 02:00 am | Interim 2022 Earnings Release |
| 2022-10-14 01:40 pm | World Muscle Society Congress - Poster : #FP.27 |
| 2022-10-14 01:30 pm | World Muscle Society Congress - Poster : #P.133 |
| 2022-10-12 03:00 pm | World Muscle Society Congress - Poster : #P.71 |
| 2022-10-12 01:40 pm | World Muscle Society Congress - Poster : #FP.03 |
| 2022-06-30 04:30 am | Annual General Meeting |
Annual results
| Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
|
Net sales Million CHF | Released Forecast Spread | 31,7 31,4 0.98% | 75,4 76,1 -0.95% | 15,0 15,0 0.05% | -1,60 8,00 -119.94% | 7,47 0,00 - | 8,29 |
|
EBITDA Million CHF | Released Forecast Spread | -47,7 -50,1 4.76% | -5,67 -1,92 -195.13% | -45,9 -42,0 -9.38% | -39,6 -25,0 -58.26% | -42,1 -35,0 -20.34% | 0,00 |
|
EBIT Million CHF | Released Forecast Spread | -51,4 -54,4 5.53% | -10,4 -5,30 -97.19% | -53,1 -51,5 -3.06% | -56,9 -29,0 -96.17% | -52,0 -39,0 -33.27% | -48,0 |
|
Earnings before Tax (EBT) Million CHF | Released Forecast Spread | -53,9 -53,4 -0.81% | -18,4 0,41 -4597.31% | -67,5 -62,5 -7.93% | -54,7 -39,0 -40.3% | -69,7 -47,0 -48.27% | 0,00 |
|
Net income Million CHF | Released Forecast Spread | -54,2 -54,4 0.45% | -19,0 0,41 -4738.88% | -67,7 -71,0 4.71% | -55,5 -39,0 -42.37% | -70,1 -47,0 -49.25% | 0,00 |
|
EPS CHF | Released Forecast Spread | -78,6 -78,5 -0.19% | -17,3 0,37 -4775.68% | -50,8 -42,3 -20.09% | -16,2 -7,20 -125% | -11,7 -6,30 -85.71% | 0,00 |
| Announcement Date | 29/04/19 | 24/03/20 | 29/04/21 | 10/06/22 | 27/04/23 | - |
Quarterly results
| Fiscal Period | December | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 |
|---|---|---|---|---|---|---|---|---|
|
Net sales Million CHF | Released Forecast Spread | 1,85 | 1,99 | 2,05 | 2,40 | 5,70 | 10,3 | 13,7 |
|
EBIT Million CHF | Released Forecast Spread | -10,5 | -11,5 | -12,6 | -13,5 | |||
| Announcement Date | - | - | - | - | - | - | - |
More events
Past sector events for Santhera Pharmaceuticals Holding AG
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- SANN Stock
- Calendar Santhera Pharmaceuticals Holding AG
